ArticleTherapeutic advances in medical oncology2025

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies.

Joan R Choo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.